atenolol has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Owczarczyk-Saczonek, A | 1 |
Znajewska-Pander, A | 1 |
Owczarek, W | 1 |
Maciejewska-Radomska, A | 1 |
Placek, W | 1 |
Gómez Torrijos, E | 1 |
García Rodríguez, C | 1 |
Sánchez Caminero, MP | 1 |
Castro Jiménez, A | 1 |
García Rodríguez, R | 1 |
Feo-Brito, F | 1 |
2 other studies available for atenolol and Acute Generalised Exanthematous Pustulosis
Article | Year |
---|---|
Clinicopathologic retrospective analysis of annular pustular psoriasis.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Aged, 80 and over; Antihypertensive Agents; Atenol | 2018 |
First case report of acute generalized exanthematous pustulosis due to labetalol.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenergic Antagonists; Adult; Antihypertensive Agents; | 2015 |